Preview

Medical alphabet

Advanced search

Problems of HBsAg mass screening and their solutions

Abstract

The Scientific and Practical Center of Dermatovenereology and Cosmetology of the Moscow Department of Healthcare, Moscow, Russian Federation. The investigation of some sera samples for hepatitis B surface antigen (HBsAg) is associated with the problem of results interpretation. The purpose of this study was to describe the problems that arise during the mass screening for HbsAg and to present some ways of their solution in order to prevent false results. Methods. The screening and confirming test systems (TS) for ELISA (including the state modification without the use of a stop reagent) have been applied. The results of screening in ELISA are denoted as the sample positivity coefficient, equal to the ratio of a sample optical density (OD) to the cut-off OD value (S/Co). Results and conclusions. The 545 HBsAg-positive results (1.21 % of screening) have been received by different means of research: 1) after a singular confirming research in 52.29 % of samples; 2) with the OD measurement without a stop reagent in 21.10 % of samples; 3) after diluting 100 and more times in 24.95 % of all HBsAg-positive samples. 17 samples were low-positive in screening (S/Co less than 3); 9 of them were identified as positive, which is 1.7 % of positive samples and 0.02 % of all the samples. Low-positive samples need to be investigated in TS with sensitivity higher than 0.01 ng/ml, because in those with less sensitivity the criteria of positivity aren 't carried out, and the results of blood sera samples research, including those received from pregnant women and newborn children, are interpreted as negative. This is also fair in regards to the research of samples received from the Federal system of research quality assessment.

About the Authors

M. M. Shulgina
Moscow Scientific and Practical Centre for Dermatovenereology and Cosmetology
Russian Federation


M. I. Ermolaeva
Moscow Scientific and Practical Centre for Dermatovenereology and Cosmetology
Russian Federation


E. V. Efremova
Moscow Scientific and Practical Centre for Dermatovenereology and Cosmetology
Russian Federation


A. A. Potapova
Moscow Scientific and Practical Centre for Dermatovenereology and Cosmetology
Russian Federation


References

1. Zhang W., Wang X., Wang Y., Zhao X., Duan W., Wang Q., Wu X., Kong Y., Ma H., You H., Ou X., Jia J. Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up // Medicine (Baltimore). -2017. -96 (44): e8454. doi: 10.1097/ MD.0000000000008454.

2. Приказ МЗ РФ № 322 от 21.10.2002 г. «О применении в практике здравоохранения иммуноферментных тест-систем для выявления поверхностного антигена вируса гепатита В (HBsAg) и антител к вирусу гепатита С (анти-ВГС) в сыворотке крови человека». Ссылка активна на 15.02.2018. http://base.garant. ru/6963112.

3. Национальный стандарт Российской Федерации. ГОСТ Р 51352-2013. Медицинские изделия для диагностики ин витро. Методы! испытаний. Ссылка активна на 15.02.2018. http://docs.pravo.ru/ document/view/60945727/69075563.

4. Нетесова И. Г., Ярославцева О. А., Цой Л. В., Жуков В. А., Нетесов С. В. Результаты участия 360 лабораторий России в Программе внешней оценки качества исследований HBsAg. // Клин. Лаб. Диагн. -2007. -3: 47-49. (In Russ.).

5. Медицинские лабораторные технологии. Т. 1. Под ред. Карпищенко А. И. СПб.: Интермедика; 1998.

6. Кюрегян К. К., Михайлов М. И. Молекулярно-биологические основы! контроля вирусных гепатитов. М.: Изд-во Икар; 2013.

7. Туполева Т. А., Игнатова Е. Н., Гуляева А. А., Овчинникова Е. Н., Тихомиров Д. С., Абакаров Р. Р., Романова Т. Ю., Ярославцева Н. Г., Королева О. М., Гаранжа Т. А., Филатов Ф. П., Гапонова Т. В., Савченко В. Г. Скрининг донорской крови на антитела к ядерному антигену вируса гепатита В как инструмент повышения безопасности трансфузий для больных заболеваниями системы крови. Клин. лаб. диагн. 2016. - 61 (5): 311-316. doi: 10.18821/0869-2084-201661-5-311-316.


Review

For citations:


Shulgina M.M., Ermolaeva M.I., Efremova E.V., Potapova A.A. Problems of HBsAg mass screening and their solutions. Medical alphabet. 2018;1(5):26-30. (In Russ.)

Views: 423


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)